Surgical management of atherosclerotic renovascular disease

Abstract

The surgical correction of atherosclerotic renovascular disease resulted in blood pressure benefit and retrieval of renal function in selected patients with hypertension. The patients with cured hypertension or improved EGFR after operation showed increased dialysis-free survival as compared with other patients who underwent surgery.

Hybrid Open Endovascular Technique for Aortic Thoracoabdominal Pathologies

“…30 In addition, the 30-day mortality rate after surgical intervention for atherosclerotic renovascular disease is suggested to be 4.6%. 31 Obviously, a combination of these surgical procedures is expected to be associated with an increased surgical risk.…”

Surgical Treatment of Abdominal Aortic Aneurysm with Congenital Solitary Pelvic Kidney and Superior Mesenteric Artery Stenosis

“…1) Among these, to the best of our knowledge, this is the first case report for treatment of AAA with Surgical correction of atherosclerotic renovascular disease can result in blood pressure benefit and improvement of renal function in patients with hypertension. 7) In our patient, surgical treatment for renovascular disease was as important as AAA repair. The treatment of SMA stenosis is controversial.…”

Renal artery stenting may not be appropriate for patients with atherosclerotic renal artery stenosis

“…Of those who have an EGFR of 39 mL/min/m 2 or greater, between 80% and 95% are alive and dialysis-free at five years. 12,21 For the purposes of this decision analysis, the minimum value was used as the preoperative EGFR of all of the patients in this study could not be ascertained. Of those patients who had a failed aortorenal bypass, only 18% are dialysis-free at five years.…”

“…Variability in inpatient mortality, incidence of complications, five-year patency, five-year mortality, and five-year dialysis-free survival was introduced using reference values from the literature. 5,7,10,12,[18][19][20][21][22][23][24][25][26][27] Variation in life expectancy was introduced using reference values in the literature and the US Census Bureau. 10,19,21 Normal distribution plots were generated from a variance-based sensitivity analysis of these factors for cost (Figure 2a …”

“…If a future value calculation is completed with the $519,334 improvement, aortorenal bypass is expected to lead to an additional 10 years of dialysis-free survival compared to just 2.4 years for patients who undergo renal artery stenting, similar to what has been previously reported. 5,10,12,19,21,23 …”